Two Sigma Securities »

Inmed Pharmaceuticals shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.4k 13k 0.42

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Inmed Pharmaceuticals

Citadel Advisors
Two Sigma Securities
BFSG
Bank of America Corporation
TD Waterhouse Canada
AdvisorNet Financial
Advisory Services Network
Advisor Group Holdings
AllSquare Wealth Management
National Bank Of Canada /fi/
Royal Bank of Canada
Global Retirement Partners
Gables Capital Management

View all funds holding Inmed Pharmaceuticals